A study of electronic medical records from US Veterans Health Administration medical centers has found that hydroxychloroquine--with or without azithromycin--did not reduce the risk of ventilation or death and was associated with longer length of hospital stay.
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19.
Analysis of Seattle emergency medical services (EMS) and hospital data from January 1 to April 15, 2020, indicates bystander CPR is a lifesaving endeavor whose benefits outweigh the risks of COVID-19 infection, according to a new article published yesterday in the American Heart Association's flagship journal Circulation.
Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin - a new class of potent natural antibiotic capable of killing superbugs.
As communities across the U.S. have struggled to cope with the effects of the COVID-19 pandemic, many have focused on the lack of widespread testing as a major barrier to safely reopening the country.
The first convalescent plasma transfusion trial results from Houston Methodist have been published. Of the study’s 25 patients, 19 have improved and 11 discharged. With no adverse side effects caused by the therapy, the study concluded convalescent plasma is a safe treatment option for patients with severe COVID-19. This is the first peer-reviewed publication in the U.S. of convalescent plasma therapy results for COVID-19.
The Society for Risk Analysis (SRA), the world’s leading authority on risk sciences and its applications, is hosting a webinar on Thursday, June 11 at 11 a.m. ET to discuss the latest research on aerosol transmission of COVID-19.
UVA Health has partnered with the Virginia Department of Health and other hospitals around the state to determine how many Virginians have been infected with COVID-19 – and how many remain at risk.
In a new study, published June 5, 2020, in the Journal of Experimental Medicine, scientists at La Jolla Institute for Immunology (LJI) shows that antibodies against JEV are “cross-reactive” and can also recognize Zika virus. Unfortunately, these antibodies can actually make Zika cases more severe.
Long-term care facilities (LTCFs) are a major driver of total COVID-19 deaths.
A new study shows there was substantial social distancing inequalities throughout New York City during the COVID-19 pandemic. Researchers reported that areas with the lowest individual income and a greater percentage of non-white and/or Hispanic/Latino individuals, used the subway to a greater degree during the pandemic, and the strongest driver of subway use in communities of color was the percent of individuals in essential work. This is one of the first studies to assess the interrelationship between sociodemographic factors, mobility, and COVID-19. Findings are online in the preprint of medRxiv ahead of peer-reviewed publication.
The Chapman University National COVID-19 and Mental Health Survey provides an in-depth look at the experiences of 4,149 adults living in the United States.
AACC has issued a new guidance document detailing best practices that hospitals and other healthcare institutions should follow when running a point-of-care testing program. As point-of-care tests emerge for more and more conditions—including COVID-19—the guidance emphasizes that it is essential for laboratory professionals and clinicians to collaborate on point-of-care testing programs to ensure this testing benefits patients.
As a leading New Jersey academic medical center and member of Hackensack Meridian Health, Jersey Shore University Medical Center is able to provide its patients access to existing clinical trials and the latest medical techniques in a variety of specialties. Currently, the medical center is recruiting individuals who have been clinically diagnosed with COVID-19 or have laboratory test results showing they have COVID-19 antibodies to donate their blood and potentially assist patients in their recovery from the virus.
Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.
Universally screening pediatric patients for COVID-19 before they undergo surgical procedures has allowed hospitals to improve safety by identifying all patients who test positive for the virus, half of whom have no symptoms, according to new research led by Children’s Hospital of Philadelphia (CHOP). The study, which analyzed universal screening procedures at CHOP and two other major children’s hospitals, found that screening patients for COVID-19 allowed hospitals to ensure patients and physicians were not exposed to the virus.
Researchers report that the Asian tiger mosquito, Aedes albopictus, has become more abundant across Illinois in the past three decades. Its spread is problematic, as the mosquito can transmit diseases - like chikungunya or dengue fever - to humans.
The UIC Innovation in COVID-19 Working Group (ICWG) was organized at UIC to assign resources to and manage COVID-19 medical-related projects.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right